furosemide has been researched along with bisoprolol in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asseman, P; Bauters, C; Darchis, J; De Groote, P; Ennezat, PV; Gonin, X; Lamblin, N; Lejemtel, T | 1 |
| Azizi, M; Bobrie, G; Boutouyrie, P; Chatellier, G; Frank, M; Laurent, S; Menard, J; Peyrard, S; Plouin, PF | 1 |
| Freeman, LJ; McKelvey, A; Sawant, RD; Stanley, KP | 1 |
| Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
| Aarons, L; Darwich, A; Dressman, J; Hansmann, S; Margolskee, A | 1 |
| Carrara, A; Conte, D; Occhipinti, V; Orlando, S; Segato, S | 1 |
| Balyklova, KS; Pomerantsev, AL; Rodionova, OY; Titova, AV | 1 |
| Attakora, J; Donkoh, IE; Ephraim, RKD; Essuman, G; Okyere, I; Okyere, P; Serwaa, D | 1 |
| Tchernev, G | 1 |
1 review(s) available for furosemide and bisoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for furosemide and bisoprolol
| Article | Year |
|---|---|
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.
Topics: Adolescent; Adult; Aged; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Bisoprolol; Blood Pressure; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nephrons; Prospective Studies; Ramipril; Renin-Angiotensin System; Spironolactone; Young Adult | 2012 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
17 other study(ies) available for furosemide and bisoprolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Delayed recovery of left ventricular systolic dysfunction: ''give time to medical therapy''.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Middle Aged; Ramipril; Spironolactone; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
Pregnancy and treatment outcome in a patient with left ventricular non-compaction.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Diuretics; Drug Therapy, Combination; Echocardiography; Female; Fibrinolytic Agents; Furosemide; Heart Failure; Heart Ventricles; Heparin, Low-Molecular-Weight; Humans; Isolated Noncompaction of the Ventricular Myocardium; Magnetic Resonance Imaging; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy Trimester, Third; Risk Factors; Treatment Outcome | 2013 |
Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models.
Topics: Administration, Intravenous; Administration, Oral; Animals; Biological Availability; Biopharmaceutics; Biotransformation; Bisoprolol; Cimetidine; Computer Simulation; Drug Compounding; Forecasting; Furosemide; Gastrointestinal Absorption; Humans; Models, Biological; Nifedipine; Permeability; Reproducibility of Results | 2016 |
ERCP or NO ERCP: the case report of a frail patient.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzodiazepines; Bisoprolol; Bronchodilator Agents; Diuretics; Emergency Service, Hospital; Enalapril; Fluticasone; Frail Elderly; Furosemide; Humans; Male; Nordazepam; Pain Management; Pancreatitis; Pantoprazole; Salmeterol Xinafoate; Thyroxine; Tomography, X-Ray Computed; Ultrasonography | 2018 |
Detection of counterfeit and substandard tablets using non-invasive NIR and chemometrics - A conceptual framework for a big screening system.
Topics: Bisoprolol; Cheminformatics; Counterfeit Drugs; Furosemide; Reference Standards; Spectroscopy, Near-Infrared; Tablets | 2019 |
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.
Topics: Adult; Aspirin; Bisoprolol; Conservative Treatment; Furosemide; Ghana; Humans; Irbesartan; Kidney Failure, Chronic; Lisinopril; Metformin; Middle Aged; Nifedipine; Ranitidine; Renal Replacement Therapy; Retrospective Studies; Sodium | 2022 |
NITROSAMINES IN COMMONLY PRESCRIBED ANTIHYPERTENSIVES AND THE (UN)CONTROLLED DRUG-INDUCED SKIN CANCER: SIMULTANEOUS DEVELOPMENT OF CUTANEOUS MELANOMA AND MULTIPLE BCC AFTER CONCOMITANT ADMINISTRATION OF BISOPROLOL AND FUROSEMIDE.
Topics: Antihypertensive Agents; Bisoprolol; Carcinogens; Furosemide; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mutagens; Nitrosamines; Quality of Life; Skin Neoplasms; United Nations | 2023 |